Vima Therapeutics · Boston tech scene from Fundable · PamPam
Vima Therapeutics
Vima Therapeutics is a Cambridge, MA–based clinical-stage biotech developing VIM0423, an oral therapy for dystonia and related movement disorders, in Phase 1 with Phase 2 planned late 2025.